Side-by-side comparison of AI visibility scores, market position, and capabilities
Global exchange group with $4.8B FY2024 revenue; SPX/VIX options monopoly; 0DTE options trading boom 2022-2024; new CEO Fred Tomczyk 2023; digital assets derivatives expansion.
Cboe Global Markets is one of the world's largest exchange holding companies, founded in 1973 as the Chicago Board Options Exchange—the world's first options exchange—and now headquartered in Chicago, Illinois, trading on Nasdaq (CBOE). The company generated approximately $4.8 billion in net revenues for FY2024 under CEO Fred Tomczyk, who succeeded longtime CEO Ed Tilly in 2023 following an ethics investigation. Cboe operates multiple asset class exchanges including U.S. options (Cboe Options Exchange, C2), U.S. equities (BZX, BYX, EDGX, EDGA), European equities and derivatives, Canadian equities (NEO Exchange), digital assets, FX, and futures, positioning itself as a global multi-asset marketplace with significant intellectual property in index derivatives.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.